Global Pharmaceuticals & Biotech Profitable Climbers

Clinuvel Pharmaceuticals

Market Cap: AU$509.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Zevra Therapeutics

Market Cap: US$502.7m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Rubicon Research

Market Cap: ₹123.8b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Camurus

Market Cap: SEK 28.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

PharmaEssentia

Market Cap: NT$255.7b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Bonesupport Holding

Market Cap: SEK 13.5b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

ChengDu ShengNuo BiotecLtd

Market Cap: CN¥5.7b

Engages in the research and development, production, sale, and export of peptide drugs.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥10.3b

A biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.

Wedge IndustrialLtd

Market Cap: CN¥18.1b

Engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Xiamen Amoytop Biotech

Market Cap: CN¥28.6b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Alvotech

Market Cap: US$1.2b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Lotus Pharmaceutical

Market Cap: NT$70.7b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

WuXi XDC Cayman

Market Cap: HK$72.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Acutaas Chemicals

Market Cap: ₹183.0b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Newron Pharmaceuticals

Market Cap: CHF 379.9m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م9.1b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

Soleno Therapeutics

Market Cap: US$2.0b

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Alnylam Pharmaceuticals

Market Cap: US$43.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Corcept Therapeutics

Market Cap: US$3.8b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$32.1b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Kexing Biopharm

Market Cap: CN¥5.7b

A biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia.

Aether Industries

Market Cap: ₹128.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

May & Baker Nigeria

Market Cap: ₦68.6b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Kiniksa Pharmaceuticals International

Market Cap: US$3.6b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Bora Pharmaceuticals

Market Cap: NT$59.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

CORONA Remedies

Market Cap: ₹95.7b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

Orchid Pharma

Market Cap: ₹27.3b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

Innova Captab

Market Cap: ₹38.3b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €11.6m

A biopharmaceutical company, engages in the precision medicine business.

Cohance Lifesciences

Market Cap: ₹111.7b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Stoke Therapeutics

Market Cap: US$2.0b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

SIGA Technologies

Market Cap: US$456.2m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

XOMA Royalty

Market Cap: US$312.8m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

RemeGen

Market Cap: HK$53.0b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.